From SUD research to impact: Lessons from Biobot with Peter Chai
The upcoming webinar will feature Dr. Peter Chai, an associate professor at Brigham and Women's Hospital and a scientific advisor at Biobot. Dr. Chai will discuss his role in securing non-dilutive government funding for substance use disorder (SUD) research and supporting the growth of a rapidly expanding startup.
Biobot, a startup originating from MIT, leverages wastewater data to assist governments and businesses in improving public health. In 2022, Biobot was recognized on TIME’s 100 Most Influential Companies List and played a crucial role during the COVID-19 pandemic by tracking infection spikes through wastewater analysis.
Outside of the ER, Dr. Chai focuses on researching and developing digital health innovations, including ingestible sensors for monitoring medication adherence, real-time behavioral interventions, wearable telemedicine, and sensorless biometric detection.
The webinar will consist of a 40-minute presentation followed by a 20-minute Q&A session with the audience.
About SUD Ventures
A program by MIT Bootcamps, SUD Ventures is an intense and immersive hybrid program. Consisting of live expert webinars, online courses, and culminating in a five day Bootcamp at MIT, our goal is to spark the creation of innovative biomedical ventures in the substance use disorder space, a notoriously challenging problem area.